Figure 5.
Kaplan–Meier curves of mPFS for patients treated with endocrine therapy after disease progression on palbociclib administered in the first-, second-, or ⩾third-line setting.
mPFS, median progression free survival.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.